Acclaro Medical is proud to announce that leading dermatologic laser experts will spotlight UltraClear® 2910 nm cold ablative ...

Title: Effect of Aficamten vs Metoprolol on Patient-Reported Health Status in Obstructive Hypertrophic Cardiomyopathy Presenter: Michael E. Nassif, M.D., University of Missouri Kansas City Healthcare ...

AVITA Medical (RCEL) announced two podium presentations at the 2025 Southern Region Burn Conference, SRBC, that collectively underscore the ...

Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that five abstracts – one oral and four ...

Investing.com -- Viking Therapeutics Inc (NASDAQ:VKTX) stock jumped 7.3% following the announcement that its VK2735 obesity program will be featured in multiple presentations at upcoming medical ...

Phase 3 TRANSCEND trial data showed setmelanotide achieved significant BMI reductions in patients with acquired hypothalamic obesity on ...

Vadodara: Navrachana University's School of Business and Law, in collaboration with the German university Europa Universitat ...

A presentation by scientists on a work group for the Centers for Disease Control and Prevention’s vaccine advisory panel ...

VCN-01 upcoming mini-oral presentation at ESMO 2025 Expanded data from the VIRAGE trial investigating VCN-01 (zabilugene almadenorepvec) are to be presented at a mini oral session at the ESMO 2025 ...

At the Hairy Cell Leukemia Foundation 2025 Conference in Bologna, Italy, we had the opportunity to sit down with Dr. Dima El-Sharkawi for a live interview. The discussion focused on how hairy cell ...

In the first hour of "Connections with Evan Dawson" on 11/10/25, we discuss the rise in misinformation or disinformation ...

Data to be featured in two oral presentations on December 8, 2025 - - Broad development program assesses ziftomenib across diverse AML segments and treatment paradigms to inform appropriate use - SAN ...